Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: Evaluation of immunity and pathology

Vaccine

Volumn 30, Issue 10, 2012, Pages 1875-1885

  Kollipara, Avinash ^a   George, Carmel ^a   Hanger, Jon ^b   Loader, Jo ^b   Polkinghorne, Adam ^a   Beagley, Kenneth ^a   Timms, Peter ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Australia Zoo Queensland   (Australia)

Author keywords

Antibody; Chlamydia; Koala; Vaccine

Indexed keywords

CHLAMYDIA PECORUM VACCINE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHLAMYDIA PECORUM; CHLAMYDIASIS; CONTROLLED STUDY; DRUG SAFETY; GENOTYPE; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; KOALA; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CHLAMYDIA; CHLAMYDIA INFECTIONS; CROSS REACTIONS; EYE; FEMALE; ISCOMS; KERATOCONJUNCTIVITIS, INFECTIOUS; MALE; PHASCOLARCTIDAE; UROGENITAL SYSTEM; VACCINES, SUBUNIT;

EID: 84857452309     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.125     Document Type: Article

References (42)

1. Rhodes J.R., Wiegand T., McAlpine C.A., Callaghan J., Lunney D., Bowen M., et al. Modelling species distributions to improve conservation in semiurban landscapes: koala case study. Conservation Biology 2006, 20(2):449-459.
2. Wilmer J., Melzer A., Carrick F., Moritz C. Low genetic diversity and inbreeding depression in Queensland Koalas. Wildlife Research 1993, 20(2):177-187.
3. Dique D.S., Thompson J., Preece H.J., Penfold G.C., De Villiers D.L., Leslie R.S. Koala mortality on roads in south-east Queensland: the koala speed-zone trial. Wildlife Research 2003, 30(4):419-426.
4. Rhodes J.R., Ng C.F., De Villiers D.L., Preece H.J., McAlpine C.A., Possingham H.P. Using integrated population modelling to quantify the implications of multiple threatening processes for a rapidly declining population. Biological Conservation 2011, 144(3):1081-1088.
5. Everett K.D.E., Bush R.M., Andersen A.A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. International Journal of Systematic Bacteriology 1999, 49(2):415-440.
6. Schachter J., Stephens R.S., Timms P., Kuo C., Bavoil P.M., Birkelund S., et al. Radical changes to chlamydial taxonomy are not necessary just yet. International Journal of Systematic and Evolutionary Microbiology 2001, 51(1):249.
7. Grayston J.T., Campbell L.A., Kuo C.C., Mordhorst C.H., Saikku P., Thom D.H., et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. Journal of Infectious Diseases 1990, 161(4):618-625.
8. Bodetti T.J., Jacobson E., Wan C., Hafner L., Pospischil A., Rose K., et al. Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Systematic and Applied Microbiology 2002, 25(1):146-152.
9. Yousef Mohamad K., Rodolakis A. Recent advances in the understanding of Chlamydophila pecorum infections, sixteen years after it was named as the fourth species of the Chlamydiaceae family. Veterinary Research 2010, 41(3):27.
10. Jackson M., White N., Giffard P., Timms P. Epizootiology of Chlamydia infections in two free-range koala populations. Veterinary Microbiology 1999, 65(4):255-264.
11. Devereaux L.N., Polkinghorne A., Meijer A., Timms P. Molecular evidence for novel chlamydial infections in the koala (Phascolarctos cinereus). Systematic and Applied Microbiology 2003, 26(2):245-253.
12. Brown A.S., Girjes A.A., Lavin M.F., Timms P., Woolcock J.B. Chlamydial disease in koalas. Australian Veterinary Journal 1987, 64(11):346-350.
13. Griffith J.E., Higgins D.P., Li K.M., Krockenberger M.B., Govendir M. Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus). Journal of Veterinary Pharmacology and Therapeutics 2010, 33(6):595-604.
14. Osawa R., Carrick F.N. Use of a dietary supplement in koalas during systemic antibiotic treatment of chlamydial infection. Australian Veterinary Journal 1990, 67(8):305-307.
15. Kaltenboeck B., Kousoulas K.G., Storz J. Structures of and allelic diversity and relationships among the major outer membrane protein (ompA) genes of the four chlamydial species. Journal of Bacteriology 1993, 175(2):487-502.
16. Batteiger B. The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope. Infection and Immunity 1996, 64(2):542-547.
17. Eko F.O., Okenu D.N., Singh U.P., He Q., Black C., Igietseme J.U. Evaluation of a broadly protective Chlamydia-Cholera combination vaccine candidate. Vaccine 2011, 29(21):3802-3810.
18. Ekong E.E., Okenu D.N., Mania-Pramanik J., He Q., Igietseme J.U., Ananaba G.A., et al. A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin. FEMS Immunology and Medical Microbiology 2009, 55(2):280-291.
19. Ifere G.O., He Q., Igietseme J.U., Ananaba G.A., Lyn D., Lubitz W., et al. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. Journal of Microbiology, Immunology and Infection 2007, 40(3):188-200.
20. Carey A.J., Timms P., Rawlinson G., Brumm J., Nilsson K., Harris J.M., et al. A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants. American Journal of Reproductive Immunology 2010, 63(2):161-172.
21. Wilkinson R., Kotlarski I., Barton M. Koala lymphoid cells: analysis of antigen-specific responses. Veterinary Immunology and Immunopathology 1992, 33(3):237-247.
22. Jackson M., Timms P. Outer membrane protein A gene sequencing demonstrates the polyphyletic nature of koala Chlamydia pecorum isolates. Systematic and Applied Microbiology 1997, 20(2):187-200.
23. Marsh J., Kollipara A., Timms P., Polkinghorne A. Novel molecular markers of Chlamydia pecorum genetic diversity in the koala (Phascolarctos cinereus). BMC Microbiology 2011, 11:77.
24. Stephens R.S., Sanchez-Pescador R., Wagar E.A., Inouye C., Urdea M.S. Diversity of Chlamydia trachomatis major outer membrane protein genes. Journal of Bacteriology 1987, 169(9):3879-3885.
25. Wan C., Loader J., Hanger J., Beagley K., Timms P., Polkinghorne A. Using quantitative polymerase chain reaction to correlate Chlamydia pecorum infectious load with ocular, urinary and reproductive tract disease in the koala (Phascolarctos cinereus). Australian Veterinary Journal 2011, 89(10):409-412.
26. Girjes A.A., Weigler B.J., Hugall A.F., Carrick F.N., Lavin M.F. Detection of Chlamydia psittaci in free-ranging koalas (Phascolarctos cinereus): DNA hybridization and immuno-slot blot analyses. Veterinary Microbiology 1989, 21(1):21-30.
27. Girjes A.A., Hugall A.F., Timms P., Lavin M.F. Two distinct forms of Chlamydia psittaci associated with disease and infertility in Phascolarctos cinereus (koala). Infection and Immunity 1988, 56(8):1897-1900.
28. Girjes A.A., Hugall A., Graham D.M., McCaul T.F., Lavin M.F. Comparison of type I and type II Chlamydia psittaci strains infecting koalas (Phascolarctos cinereus). Veterinary Microbiology 1993, 37(1-2):65-83.
29. Cockram F.A., Jackson A.R. Keratoconjunctivitis of the koala (Phascolarctos cinereus) caused by Chlamydia psittaci. Journal of Wildlife Diseases 1981, 17(4):497-504.
30. Canfield P.J., Love D.N., Mearns G., Farram E. Chlamydial infection in a colony of captive koalas. Australian Veterinary Journal 1991, 68(5):167-169.
31. Stevenson I. Chlamydia and the demise of the koala. Microbiological Sciences 1986, 3(7):202.
32. McColl K.A., Martin R.W., Gleeson L.J., Handasyde K.A., Lee A.K. Chlamydia infection and infertility in the female koala (Phascolarctos cinereus). The Veterinary Record 1984, 115(25-26):655.
33. Govendir M., Hanger J., Loader J.J., Kimble B., Griffith J.E., Black L.A., et al. Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis. Journal of Veterinary Pharmacology and Therapeutics 2011.
34. Cappello F., Conway de Macario E., Di Felice V., Zummo G., Macario A.J. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathogens 2009, 5(8):1000552.
35. Higgins D.P., Hemsley S., Canfield P.J. Association of uterine and salpingeal fibrosis with chlamydial hsp60 and hsp10 antigen-specific antibodies in Chlamydia-infected koalas. Clinical and Diagnostic Laboratory Immunology 2005, 12(5):632-639.
36. Linhares I.M., Witkin S.S. Immunopathogenic consequences of Chlamydia trachomatis 60kDa heat shock protein expression in the female reproductive tract. Cell Stress & Chaperones 2010, 15(5):467-473.
37. Cunningham K.A., Carey A.J., Timms P., Beagley K.W. CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice. Vaccine 2010, 28(31):4861-4863.
38. Sun G., Pal S., Weiland J., Peterson E.M., de la Maza L.M. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine 2009, 27(36):5020-5025.
39. Pal S., Luke C.J., Barbour A.G., Peterson E.M., de la Maza L.M. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine 2003, 21(13-14):1455-1465.
40. Cheng C., Pal S., Bettahi I., Oxford K.L., Barry P.A., de la Maza L.M. Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine 2011, 29(18):3456-3464.
41. Kari L., Whitmire W.M., Crane D.D., Reveneau N., Carlson J.H., Goheen M.M., et al. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. The Journal of Immunology 2009, 182(12):8063-8070.
42. Larsen J., Lund O., Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Research 2006, 2(1):2.